A Like Vision: what forces molded the Group of Seven?

Biography:
Ian A C Dejardin is an art historian, exhibition curator and museum professional.

From April 2017 Ian has held the position of Executive Director for the McMichael Canadian Art Collection in Kleinburg, Ontario. In 2005 he succeeded Desmond Shawe-Taylor as Director of Dulwich Picture Gallery having held the position of Curator of that Gallery’s famous permanent collection of European Old Master paintings from

1998. While at Dulwich, Ian co-curated Henry Moore at Dulwich Picture Gallery (2004); Painting Canada: Tom Thomson and the Group of Seven (2011); Emily Carr: From the Forest to the Sea (2014); and Vanessa Bell (2017), the latter two exhibitions in collaboration with Sarah Milroy, with whom he has also co-curated David Milne: Modern Painting (2018; at Dulwich Picture Gallery, the Vancouver Art Gallery and the McMichael Canadian Art Collection).

He has organised numerous other exhibitions for the Gallery and authored the Gallery’s publication, Director’s Choice (2006), published by Scala (something he has also done for the McMichael Canadian Art Collection in 2018). 2019 Lionel LeMoine FitzGerald: Into the Light (co-curator)

Ian A. C. Dejardin holds an MA (Hons) in History of Art from the University of Edinburgh. He completed a postgraduate Diploma in Art Gallery and Museum Studies at Manchester University. He started his career as a curatorial assistant at the Royal Academy of Arts, then spent seven years with English Heritage, firstly as Senior Curator of Paintings for the London Region, responsible for, amongst others, the collection at Kenwood House; then as Head of Historic Team.

Dr. Michael Verbora MBA, MD, Chief Medical Officer, Aleafia Health, Assistant Professor, McMaster University, Student Health Physician, Seneca College

The Medical use of Cannabis
Dr. Michael Verbora earned an MBA from the Odette School of Business in 2009 and an M.D. from Schulich School of Medicine at Western University in 2013, before entering Family Practice residency at the University of Toronto.

To date he has completed over 5,000 cannabinoid therapy consultations, and is a global medical expert in the field of cannabinoid therapy. He has given over one hundred presentations on cannabinoid therapy, including internationally to government, parliament and regulators.

He serves as Chief Medical Officer of Aleafia Health, a Canadian Producer of medical cannabis and cannabinoid research.

Dr. Michael Verbora is a family physician who works in the Toronto community. When graduating at the peak of the opioid crisis he sought out other therapies to help patients with pain. He came across medical cannabis and with self education became passionate about using this as a safer alternative to opioids.

His studies in cannabis led to him becoming a global expert in cannabinoid therapy. He has treated thousands of patients and has perhaps the largest pediatric population on medical cannabis here in Toronto. He helps children with epilepsy, autism and cancer using medical cannabis safely.

He is now the Chief Medical Officer of Aleafia Health, a cannabis company in Vaughan, that is focused on creating medical cannabis medicines for patients in Canada and around the world. Dr. Verbora testifies when required as a medical expert in the field of cannabinoid medicine and has helped other governments around the world develop cannabis policy. He is an advocate for medical cannabis access for patients and patient centered medical care.